Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Arrhythmia and Electrophysiology
Search: search_blue_button Advanced Search
Published Online
on September 12, 2009

Circulation: Arrhythmia and Electrophysiology. 2009
Published online before print September 12, 2009, doi: 10.1161/CIRCEP.109.891440
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cheng, J.
Right arrow Articles by Ackerman, M. J.
PubMed
Right arrow Articles by Cheng, J.
Right arrow Articles by Ackerman, M. J.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrow Genetics of cardiovascular disease
Right arrow Clinical genetics
Right arrow Arrythmias-basic studies

Original Research Article

{alpha}1-Syntrophin Mutations Identified in Sudden Infant Death Syndrome Cause an Increase in Late Cardiac Sodium Current

Jianding Cheng1; David W. Van Norstrand2; Argelia Medeiros–Domingo2; Carmen Valdivia1; Bi–hua Tan1; Bin Ye1; Stacie Kroboth1; Matteo Vatta3; David J. Tester2; Craig T. January1; Jonathan C. Makielski1 and Michael J. Ackerman2,4

1 University of Wisconsin, Madison, WI;
2 Mayo Clinic, Rochester, MN;
3 Texas Children's Hospital & Baylor College of Medicine, Houston, TX

* Corresponding author; email: ackerman.michael{at}mayo.edu

Background—Sudden infant death syndrome (SIDS) is a leading cause of death during the first 6 months after birth. About 5%-10% of SIDS may stem from cardiac channelopathies like long QT syndrome (LQTS). We recently implicated mutations in {alpha}1-syntrophin (SNTA1) as a novel cause of LQTS, whereby mutant SNTA1 released inhibition of associated neuronal nitric oxide synthase (nNOS) by the plasma membrane Ca-ATPase PMCA4b causing increased peak and late sodium current (INa) via S-nitrosylation of the cardiac sodium channel. This study determined the prevalence and functional properties of SIDS-associated SNTA1 mutations.

Methods and Results—Using PCR, DHPLC, and DNA sequencing of SNTA1's open reading frame, 6 rare (absent in 800 reference alleles) missense mutations (G54R, P56S, T262P, S287R, T372M and G460S) were identified in 8 (~3%) out of 292 SIDS cases. These mutations were engineered using PCR-based overlap-extension and were co-expressed heterologously with SCN5A, nNOS and PMCA4b in HEK293 cells. INa was recorded using the whole-cell method. A significant 1.4-1.5 fold increase in peak INa and 2.3-2.7 fold increase in late INa compared with controls was evident for S287R-, T372M-, and G460S-SNTA1, and was reversed by an nNOS inhibitor. These 3 mutations also caused a significant depolarizing shift in channel inactivation thereby increasing the overlap of the activation and inactivation curves to increase window current.

Conclusions—Abnormal biophysical phenotypes implicate mutations in SNTA1 as a novel pathogenic mechanism for the subset of channelopathic SIDS. Functional studies are essential to distinguish pathogenic perturbations in channel interacting proteins like {alpha}1-syntrophin from similarly rare but innocuous ones.

Key Words: death, sudden (if surviving, use heart arrest) • genetics • ion channels • long-QT syndrome • nitric oxide synthase